Cost-Effectiveness of Preventive Strategies for Women with a BRCA1 or a BRCA2 Mutation-Reference-Cited by-同舟云学术

Cost-Effectiveness of Preventive Strategies for Women with a BRCA1 or a BRCA2 Mutation

Published:2006-03-21 Issue:6 Volume:144 Page:397
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Anderson Kristin¹,Jacobson Judith S.¹,Heitjan Daniel F.¹,Zivin Joshua Graff¹,Hershman Dawn¹,Neugut Alfred I.¹,Grann Victor R.¹

Affiliation:

1. From the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Joseph L. Mailman School of Public Health, Columbia University, and New York Presbyterian Hospital, New York, New York, and the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil;Breast Cancer Research and Treatment;2023-03-07

2. Impact of lower co-payments on risk-reducing salpingo-oophorectomy and BRCA testing in Japan;Archives of Public Health;2023-02-27

3. Cost-Effectiveness of Risk-Reducing Surgery for Breast and Ovarian Cancer Prevention: A Systematic Review;Cancers;2022-12-12

4. Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy;International Journal of Environmental Research and Public Health;2022-09-23

5. Optimal breast cancer risk reduction policies tailored to personal risk level;Health Care Management Science;2022-06-10